Pembrolizumab,Lenvatinib,Sunitinib,Everolimus
merck,pfizer,eisai
['thank you']
 seeing that hrqol was also a secondary endpoint in this study. can you please point to where that is reported amidst this data? thank you. really important to #kidneycancer patients.
Patient advocate for kidney cancer. Former roles with @KidneyCancer_Ca and @IKCCorg, Patient Advocate NCI Renal Task Force, Volunteer. Tweets= personal views.